Last updated: July 17, 2026

Application No. 18/820,925

PRODUCTION OF PROTEINS IN GLUTAMINE-FREE CELL CULTURE MEDIA

Non-Final OA

Filed

Aug 30, 2024

Priority

Aug 11, 2009 — provisional 61/232,889 +8 more

Examiner

MOEHLMAN, ANDREW TERRY

Art Unit

1655

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Genentech Inc.

OA Round

1 (Non-Final)

Interview Optional

— +59.0% interview lift. Examiner has a relatively high allowance rate (68%); +59.0% interview lift. A written response may suffice.

Based on 90 resolved cases, 2023–2026

Examiner Intelligence

MOEHLMAN, ANDREW TERRY View full profile →

Grants 68% — above average

Career Allowance Rate

61 granted / 90 resolved

+7.8% vs TC avg

Strong +59% interview lift

Without

With

+59.0%

Interview Lift

resolved cases with interview

Typical timeline

3y 3m

Avg Prosecution

29 currently pending

Career history

129

Total Applications

across all art units

Statute-Specific Performance

§101

7.1%

-32.9% vs TC avg

§103

45.4%

+5.4% vs TC avg

§102

8.8%

-31.2% vs TC avg

§112

14.6%

-25.4% vs TC avg

Black line = Tech Center average estimate • Based on career data from 90 resolved cases

Prosecution Timeline

Aug 30, 2024

Application Filed

May 20, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/866,499

Patent 12680072

Mycomaterial Processing in Liquid Medium

3y 12m to grant Granted Jul 14, 2026

17/759,918

Patent 12673977

HETEROLOGOUS PROTEINS WITH AXONEMAL PROTEINS

3y 11m to grant Granted Jul 07, 2026

18/300,634

Patent 12648987

ALKALINE PHOSPHATASE AGENTS FOR TREATMENT OF RADIATION DISORDERS

3y 1m to grant Granted Jun 09, 2026

18/813,643

Patent 12637493

ENGINEERED MCP AND PCP PROTEINS AND SYSTEMS AND METHODS THEREOF

1y 9m to grant Granted May 26, 2026

17/246,266

Patent 12630812

Subtilase Variants And Polynucleotides Encoding Same

5y 0m to grant Granted May 19, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

68%

Grant Probability

99%

With Interview (+59.0%)

3y 3m (~1y 4m remaining)

Median Time to Grant

Low

PTA Risk

Based on 90 resolved cases by this examiner. Grant probability derived from career allowance rate.